enGene Holdings Inc. ENGN
ENGN
enGene Holdings Inc. KRRO
Korro Bio, Inc. MBX
MBX Biosciences, Inc. Common Stock ADCT
ADC Therapeutics S.A. FDMT
4D Molecular Therapeutics, Inc. QSI
Quantum-Si incorporated RCKT
Rocket Pharmaceuticals, Inc. DBVT
DBV Technologies S.A. FULC
Fulcrum Therapeutics, Inc. AUTL
Autolus Therapeutics plc
enGene Holdings Inc. KRRO
Korro Bio, Inc. MBX
MBX Biosciences, Inc. Common Stock ADCT
ADC Therapeutics S.A. FDMT
4D Molecular Therapeutics, Inc. QSI
Quantum-Si incorporated RCKT
Rocket Pharmaceuticals, Inc. DBVT
DBV Technologies S.A. FULC
Fulcrum Therapeutics, Inc. AUTL
Autolus Therapeutics plc
Performance
| Periode | ENGN | KRRO | MBX | ADCT | FDMT | QSI | RCKT | DBVT | FULC | AUTL |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 134.34 % | 209.02 % | 73.04 % | 231.71 % | 219.48 % | 109.17 % | -48.26 % | 90.24 % | 159.83 % | 12.50 % |
| YTD | 32.44 % | 2.75 % | -27.56 % | 104.00 % | 68.78 % | -46.48 % | -70.83 % | 421.54 % | 85.74 % | -38.40 % |
| 1Y | 3.66 % | -47.34 % | -45.08 % | 30.77 % | 15.36 % | 179.45 % | -80.29 % | 282.62 % | 156.13 % | -66.25 % |
| 3Y | -53.25 % | -53.17 % | -44.10 % | -17.07 % | 30.33 % | -17.99 % | -78.93 % | 2.73 % | 28.80 % | -49.38 % |
| 5Y | -53.25 % | -96.03 % | -44.10 % | -85.76 % | -75.70 % | -76.92 % | -86.83 % | 5.28 % | -15.27 % | -86.34 % |
| 10Y | -53.25 % | -93.85 % | -44.10 % | -86.24 % | -75.70 % | -76.92 % | -91.70 % | -89.88 % | -33.41 % | -93.52 % |
| Depuis le début | -53.25 % | -93.85 % | -44.10 % | -86.24 % | -75.70 % | -76.92 % | -84.54 % | -85.20 % | -33.41 % | -93.52 % |